Search results

  1. SNT Gatchaman

    Stable cortical body maps before and after arm amputation, 2025, Schone et al.

    Commentary in Nature: The brain’s map of the body is surprisingly stable — even after a limb is lost
  2. SNT Gatchaman

    Stable cortical body maps before and after arm amputation, 2025, Schone et al.

    Stable cortical body maps before and after arm amputation The adult brain’s capacity for cortical reorganization remains debated. Using longitudinal neuroimaging in three adults, followed before and up to 5 years after arm amputation, we compared cortical activity elicited by movement of the...
  3. SNT Gatchaman

    The symptom signaling theory of ME/CFS involving neurons and their synapses

    Not always. Currently chronic traumatic encephalopathy is only confirmed post-mortem. In vivo neuroimaging techniques are still at the "promising" stage.
  4. SNT Gatchaman

    A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia, 2025, Jacobs et al.

    From commentary Rare skeletal condition caused by enzyme’s failure to rescue a catalytic cycle —
  5. SNT Gatchaman

    A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia, 2025, Jacobs et al.

    A missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia Living cells depend on an intricate network of chemical reactions catalysed by enzymes, which sometimes make mistakes that lead to their inactivation. Here we report a metabolite-based mechanism for preserving enzyme...
  6. SNT Gatchaman

    SLC45A4 is a pain gene encoding a neuronal polyamine transporter, 2025, Middleton et al.

    SLC45A4 is a pain gene encoding a neuronal polyamine transporter Polyamines are regulatory metabolites with key roles in transcription, translation, cell signalling and autophagy1. They are implicated in multiple neurological disorders, including stroke, epilepsy and neurodegeneration, and can...
  7. SNT Gatchaman

    Preprint Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial, 2025, Bramante et al.

    Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial BACKGROUND The effect of metformin on preventing long-term COVID-19 symptoms among low-risk adults has not been studied. The objective of this study was to Assess metformin compared with placebo...
  8. SNT Gatchaman

    The symptom signaling theory of ME/CFS involving neurons and their synapses

    Regarding a table of genes including neuroligin-1, Not necessarily exclusively though. Neuroligins are cell adhesion molecules that may be involved in immune cells also (both CNS and peripheral). They also relate to endothelial and vascular smooth muscle cells. There may be links to...
  9. SNT Gatchaman

    Interferon-Linked Lipid and Bile Acid Imbalance Uncovered in Ankylosing Spondylitis in a Sibling-Controlled Multi-Omics Study, 2025, Wang et al.

    In Multi-omic insights from a multi-ancestry genome-wide meta-analysis of ankylosing spondylitis reveal novel pathways of disease susceptibility (2025) — rs4848370 (nearby ACOXL) OR = 0.92, p 8x10-12
  10. SNT Gatchaman

    Interferon-Linked Lipid and Bile Acid Imbalance Uncovered in Ankylosing Spondylitis in a Sibling-Controlled Multi-Omics Study, 2025, Wang et al.

    Posting due to previous discussions relating to Ank Spond and the potential for broadly similar mechanistic explanations that might be seen in ME. Eg
  11. SNT Gatchaman

    Interferon-Linked Lipid and Bile Acid Imbalance Uncovered in Ankylosing Spondylitis in a Sibling-Controlled Multi-Omics Study, 2025, Wang et al.

    Interferon-Linked Lipid and Bile Acid Imbalance Uncovered in Ankylosing Spondylitis in a Sibling-Controlled Multi-Omics Study Ankylosing spondylitis (AS) displays wide inter-patient variability that is not accounted for by HLA-B27 alone, suggesting that additional immune and metabolic...
  12. SNT Gatchaman

    Article: Tremors, seizures and paralysis: this brain disorder is more common than multiple sclerosis – but often goes undiagnosed (FND)

    Grant recipient of NZ govt Health Research Council 260K award https://www.hrc.govt.nz/resources/research-repository/shining-light-functional-neurological-disorder-aotearoa-new-zealand Year: 2025 Duration: 36 months Approved budget: $260,000.00 Researchers: Mr Benjamin Scrivener, Professor...
Back
Top Bottom